Goodwin Advises Owlo on €1.5 Million Fundraising to Develop Innovative IVF Microscope

"Goodwin advised Owlo on a €1.5 million funding round to support development of a non‑invasive, real‑time 3D microscope module for in vitro fertilization. The round was led by Daphni, the Cercle de Chiron life‑sciences angels club, IXCore Groupe, FI8C and investor Alain Decombe (Dechert). Owlo targets CE marking and clinical rollout in 2026."

Goodwin represented Owlo in its €1.5 million fundraising round. The financing round was led by Daphni together with the new life‑sciences business angels club Cercle de Chiron, IXCore Groupe (founded by Hervé Arditty, formerly of iXblue), FI8C (Thibault Courthéoux of Nanolive) and investor Alain Decombe (Dechert). The proceeds will be dedicated to the development of an innovative microscope for in vitro fertilization (IVF). Founded in 2024, Owlo is a deeptech spin‑out from the Institut Langevin under CNRS supervision. The company develops a non‑invasive, real‑time 3D cellular imaging module for microscopes combined with software and AI, intended to improve oocyte and embryo selection. Owlo aims to obtain CE marking and commence clinical deployment in 2026. Goodwin represented Owlo with a team composed by: Anne‑Charlotte Rivière (partner, corporate), Joséphine Remoussenard (associate, corporate) and Marie Fillon (partner, intellectual property).

Goodwin Advises Owlo on €1.5 Million Fundraising to Develop Innovative IVF Microscope

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads